Beta-Blockers After PCI for Stable Coronary Artery Disease and Preserved Left Ventricular Ejection Fraction

Background: Limited data exist on the long-term impact of beta-blocker therapy after percutaneous coronary intervention (PCI) in patients with stable coronary artery disease (CAD) and preserved left ventricular ejection fraction (LVEF). Objectives: The aim of the study was to evaluate the effects of...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	JACC: Advances
المؤلفون الرئيسيون:	Safi U. Khan, MD, MS, Usman Ali Akbar, MD, Muhammad Shahzeb Khan, MD, Kershaw V. Patel, MD, Amna Nadeem, MBBS, Samarth Thakkar, MD, Hassaan B. Arshad, MD, Salim S. Virani, MD, PhD, Khurram Nasir, MD, MPH, Sachin S. Goel, MD, Alpesh R. Shah, MD, William Zoghbi, MD, Neal S. Kleiman, MD
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2025-02-01
الموضوعات:	beta-blocker percutaneous coronary intervention stable ischemic heart disease target-trial emulation
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2772963X24008470